| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/04/2002 | EP1235749A1 A method for anion-exchange adsorption and thioether anion-exchangers |
| 09/04/2002 | EP1235748A2 A method for anion-exchange adsorption and anion-exchangers |
| 09/04/2002 | EP1105508B1 Method for purifying biomolecule or protein complexes |
| 09/04/2002 | EP0920447B1 Process of purification of cyclosporin |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/04/2002 | EP0832104B1 Dolastatin derivatives, their preparation and use |
| 09/04/2002 | CN1367789A Synthesis of template-fixed beta-hairpin loop mimetics |
| 09/04/2002 | CN1367710A Static separation method using non-porous cellulose beads |
| 09/04/2002 | CN1367178A Technological process for extracting and purifying deer's fetus extract |
| 09/03/2002 | US6446010 Method for assessing significance of protein identification |
| 09/03/2002 | US6444793 Hydrophobically-modified hedgehog protein compositions and methods |
| 09/03/2002 | US6444787 Vaccines |
| 09/03/2002 | US6444226 Purification and stabilization of peptide and protein pharmaceutical agents |
| 09/03/2002 | US6444111 Solid phase synthesis method for the preparation of diverse sequences of separate polymers or nucleic acid sequences using electrochemical placement of monomers of nucleic acids at a specific location on a substrate containing at least one |
| 09/03/2002 | CA2212052C N.alpha.-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids |
| 08/29/2002 | WO2002066713A1 High-throughput biomolecular crystallisation and biomolecular crystal screening |
| 08/29/2002 | WO2002065853A2 Catalyst modification to enhance neotame production |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002016409A3 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 08/29/2002 | WO2002016022A3 Novel strategie for synthesising polymers on surfaces |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120405 Protein data analysis |
| 08/29/2002 | US20020120109 Biologically active proteins |
| 08/29/2002 | US20020120105 Polarization switching to control crystal form |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020119539 Isolation of purified tgf -beta1 and tgf -beta2 from bone tissue |
| 08/29/2002 | US20020119492 Modulating immunogenicity of a target protein; obtain protein sequence, record in computer, screen library for preferental amino acid sequences |
| 08/29/2002 | US20020119484 Detection and measure of preferential messenger ribonucleic acid; isolate nucleotide sequences from sample, amplify, hybridize to microaray, incubate with probes, detect amount of amplicon hybridized to probe |
| 08/29/2002 | US20020119457 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
| 08/29/2002 | US20020119096 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 08/28/2002 | EP1234179A2 Naive screening method |
| 08/28/2002 | EP1233987A1 Immobilized single domain antigen-binding molecules |
| 08/28/2002 | EP1233985A1 Collagen |
| 08/28/2002 | EP1119528B1 Chemical constructs and their uses |
| 08/28/2002 | EP0988063B1 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 08/28/2002 | EP0956155B1 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| 08/28/2002 | CN1366539A Solid carrier based on linking agent for peptide and small molecular organic synthesis |
| 08/28/2002 | CN1365975A Condensation reagent and its preparation method |
| 08/28/2002 | CN1089617C Novel attinity ligands and their use |
| 08/28/2002 | CN1089609C Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 08/27/2002 | US6441147 Batch commercial scale isolation of concentrated, active natural or recombinant proteins from intercellular material via vacuum and centrifugation; nondestructive to plants; pharmaceutical quality enzymes, cytokines and antibodies |
| 08/27/2002 | US6441146 Affinity immobilized metal resins |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441136 Polypeptide of given amino acid sequence, modified by deleting amino acids near binding domains to prevent reaction with polyethylene glycol during conjugation to provide conjugated peptides with no decrease in activity |
| 08/27/2002 | US6440667 Analysis of target molecules using an encoding system |
| 08/27/2002 | US6440412 Purified forms of DNase |
| 08/27/2002 | US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
| 08/27/2002 | CA2207760C Anti alpha-galactosyl screening technique |
| 08/27/2002 | CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
| 08/27/2002 | CA1341386C Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method |
| 08/23/2002 | WO2003102013A2 Methods and compositions for production of recombinant peptides |
| 08/23/2002 | CA2444480A1 Methods and compositions for production of recombinant peptides |
| 08/22/2002 | WO2002065125A1 Methods and compositions for isolation of biological macromolecules |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064734A2 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | WO2002064622A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 08/22/2002 | WO2002064619A2 Peptides that inhibit poly-glutamine aggregation |
| 08/22/2002 | WO2002005959A3 Adsorption method and ligands |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | US20020115834 New process for the production of biologically active protein |
| 08/22/2002 | US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders |
| 08/22/2002 | US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115157 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof |
| 08/22/2002 | US20020115152 Expression system for factor VIII |
| 08/22/2002 | US20020114734 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2436889A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 08/22/2002 | CA2436789A1 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/21/2002 | EP1233065A1 G-CSF analog compositions and methods |
| 08/21/2002 | EP1232183A2 Peptides having antiangiogenic activity |
| 08/21/2002 | EP1231992A1 Method for separating cells and biomolecules using counter-current chromatography |
| 08/21/2002 | EP1231943A1 Interferon gamma conjugates |
| 08/21/2002 | EP0804456B1 Peptide nucleic acid conjugates |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437102 Method of separating prions from biological materials |
| 08/20/2002 | US6437101 Separation of human growth hormone, a derivative, or antagonist |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436665 Providing in vitro translated protein attached to nucleic acid linker, binding encoding molecule to nucleic acid linker, thereby encoding protein |
| 08/20/2002 | US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/20/2002 | CA1341385C Mutation of human granulocyte colony stimulating factor to allow the addition of carbohydrate chains at novel positions |
| 08/15/2002 | WO2002063288A1 Microfluidic devices |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062827A2 Improved protein disaggregation and refolding using high pressure |